Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Single-blind, Adaptive Dose Finding Study of Single Intravenous Injections of BAY 1747846 With Corresponding Blinded Read in Adult Participants With Known or Highly Suspected CNS Lesions Referred for Contrast-enhanced MRI of the CNS

NCT04307186 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04307186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04307186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Single-blind, Adaptive Dose Finding Study of Single Intravenous Injections of BAY 1747846 With Corresponding Blinded Read in Adult Participants With Known or Highly Suspected CNS Lesions Referred for Contrast-enhanced MRI of the CNS
Lead sponsor
Bayer
Phase
Phase 2
Overall status
Completed
Start date
November 18, 2020
Completion date
September 6, 2022
Enrollment
57 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system pathology